Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.39 |
| ▸ | FKBP5 | Q13451 | 1/20 | 0.39 |
| ▸ | PGK1 | P00558 | 1/20 | 0.35 |
| ▸ | PGK2 | P07205 | 1/20 | 0.35 |
| ▸ | LPAR1 | Q92633 | 7/20 | 0.35 |
| ▸ | LPAR5 | Q9H1C0 | 2/20 | 0.35 |
| ▸ | LPAR6 | P43657 | 1/20 | 0.35 |
| ▸ | LPAR4 | Q99677 | 1/20 | 0.35 |
| ▸ | LPAR2 | Q9HBW0 | 1/20 | 0.35 |
| ▸ | LPAR3 | Q9UBY5 | 1/20 | 0.35 |
| ▸ | ENPP2 | Q13822 | 1/20 | 0.35 |
| ▸ | PGD | P52209 | 3/20 | 0.33 |
| ▸ | MPI | P34949 | 1/20 | 0.33 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Glycerin SCHEMBL1535282 | 0.84 | ALDH1A1 (0.48) | ALDH1A1FKBP5 | |
| Glycerin SCHEMBL23579100 | 0.78 | ALDH1A1 (0.59) | ALDH1A1FKBP5 | |
| Glycerin SCHEMBL231119 | 0.78 | ALDH1A1 (0.59) | ALDH1A1FKBP5 | |
| Glycerin SCHEMBL23579221 | 0.78 | ALDH1A1 (0.59) | ALDH1A1FKBP5 | |
| SCHEMBL213379 | 0.78 | PGK1 (0.52) | ALDH1A1PGK1PGK2LPAR1LPAR5 | |
| SCHEMBL6655023 | 0.78 | PGK1 (0.52) | ALDH1A1PGK1PGK2LPAR1LPAR5 | |
| SCHEMBL7340 | 0.78 | PGK1 (0.52) | ALDH1A1PGK1PGK2LPAR1LPAR5 | |
| SCHEMBL14278848 | 0.78 | PGK1 (0.52) | ALDH1A1PGK1PGK2LPAR1LPAR5 | |
| SCHEMBL14278847 | 0.78 | PGK1 (0.52) | ALDH1A1PGK1PGK2LPAR1LPAR5 | |
| SCHEMBL7341 | 0.78 | PGK1 (0.52) | ALDH1A1PGK1PGK2LPAR1LPAR5 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 190 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119220476-B | Recombinant escherichia coli construction and application for improving yield of difucosyl lactose | 天津合生领航生物科技有限公司 | 2025-02-28 | — | — | CN | claimed |
| US-20240124907-A1 | Engineered Biosynthetic Pathways for Production of Histamine by Fermentation | ZYMERGEN INC. (US) | 2024-04-18 | — | — | US | claimed |
| US-11739355-B2 | Engineered biosynthetic pathways for production of histamine by fermentation | ZYMERGEN INC. (US) | 2023-08-29 | — | — | US | claimed |
| US-20060034817-A1 | Cloning, overexpression and therapeutic use of bioactive histidine ammonia lyase | UNIVERSITY OF SOUTH CAROLINA | 2006-02-16 | — | — | US | claimed |
| EP-0688210-B1 | USE OF CARNOSINE IN COMBINATION WITH UROCANIC ACID FOR TREATMENT OF PHOTODERMATOSES | BEIERSDORF AG (DE) | 2004-02-25 | — | — | EP | claimed |
| US-5723482-A | CARNOSINE OR DERIVATIVE, UROCANIC ACID OR DERIVATIVE | BEIERSDORF AG (DE) | 1998-03-03 | — | — | US | claimed |
| EP-0813602-A1 | HERBICIDE RESISTANT PLANTS | Ciba-Geigy Japan Limited (JP) | 1997-12-29 | — | — | EP | claimed |
| US-5541310-A | DNA ENCODING IMIDAZOLEGLYCEROL PHOSPHATE DEHYDRATASE | CIBA-GEIGY CORPORATION (US) | 1996-07-30 | — | — | US | claimed |
| EP-0688210-A1 | USE OF CARNOSINE OR A COMBINATION WITH UROCANIC ACID FOR TREATMENT OF PHOTODERMATOSES | Beiersdorf Aktiengesellschaft (DE) | 1995-12-27 | — | — | EP | claimed |
| WO-1994026909-A1 | HERBICIDE RESISTANT PLANTS | JAPAT LTD. (CH) | 1994-11-24 | — | — | WO | claimed |
| WO-1994021245-A1 | USE OF CARNOSINE OR A COMBINATION WITH UROCANIC ACID FOR TREATMENT OF PHOTODERMATOSES | BEIERSDORF AG (DE) | 1994-09-29 | — | — | WO | claimed |
| US-20260125432-A1 | MALTOSE DEPENDENT DEGRONS, MALTOSE-RESPONSIVE PROMOTERS, STABILIZATION CONSTRUCTS, AND THEIR USE IN PRODUCTION OF NON-CATABOLIC COMPOUNDS | AMYRIS INC (US) | 2026-05-07 | — | — | US | disclosed |
| US-12516090-B2 | Maltose dependent degrons, maltose-responsive promoters, stabilization constructs, and their use in production of non-catabolic compounds | Amyris, Inc. (US) | 2026-01-06 | — | — | US | disclosed |
| US-20250352486-A1 | NANOPARTICLES FOR USE IN THE TREATMENT OF INFECTIONS CAUSED BY BIOFILMS | UNIVERSITAT POLITÈCNICA DE VALÈNCIA (ES) | 2025-11-20 | — | — | US | disclosed |
| EP-4647496-A1 | NOVEL PROMOTER AND USE THEREOF | CJ CheilJedang Corporation (KR) | 2025-11-12 | — | — | EP | disclosed |
| WO-1995014385-A1 | TRIAZOLE PHOSPHONATE PESTICIDES | AGREVO UK LIMITED (GB) | 1995-06-01 | — | — | WO | disclosed |
| WO-1995011969-A1 | METHODS FOR SCREENING FOR ANTIMYCOTICS | RIBOGENE, INC. (US) | 1995-05-04 | — | — | WO | disclosed |
| WO-1994026909-A1 | HERBICIDE RESISTANT PLANTS | JAPAT LTD. (CH) | 1994-11-24 | — | — | WO | disclosed |
| WO-1994021245-A1 | USE OF CARNOSINE OR A COMBINATION WITH UROCANIC ACID FOR TREATMENT OF PHOTODERMATOSES | BEIERSDORF AG (DE) | 1994-09-29 | — | — | WO | disclosed |
| EP-0054223-A2 | Plasmid vectors for eukaryotic cells and method for selecting transfected eukaryotic cells | F. HOFFMANN-LA ROCHE & CO. Aktiengesellschaft (CH) | 1982-06-23 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260125432-A1 | MALTOSE DEPENDENT DEGRONS, MALTOSE-RESPONSIVE PROMOTERS, STABILIZATION CONSTRUCTS, AND THEIR USE IN PRODUCTION OF NON-CATABOLIC COMPOUNDS | MAX, JUND, MYCBP | ALDH1A1 4768/4885FKBP5 653/4885PGK1 1371/4885 |
| US-20060034817-A1 | Cloning, overexpression and therapeutic use of bioactive histidine ammonia lyase | HEXB, AHCYL1, HRH1 | ALDH1A1 1530/4885FKBP5 2688/4885PGK1 1071/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.